N
QTTB icon

Nuveen’s Q32 Bio QTTB Stock Holding History

Nuveen’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-55,886
Closed -$92.2K – 3439
2025
Q1 		$92.2K Hold
55,886
– – ﹤0.01% 3222
2024
Q4 		$192K Hold
55,886
– – ﹤0.01% 3211
2024
Q3 		$2.49M Buy
+55,886
New +$2.05M ﹤0.01% 2313
2022
Q2 		– Sell
-10,977
Closed -$664K – 3515
2022
Q1 		$664K Buy
10,977
+784
+8% +$48.7K ﹤0.01% 2932
2021
Q4 		$668K Sell
10,193
-619
-6% -$60.1K ﹤0.01% 2991
2021
Q3 		$1.53M Sell
10,812
-2,605
-19% -$332K ﹤0.01% 2798
2021
Q2 		$1.76M Buy
13,417
+5,722
+74% +$714K ﹤0.01% 2774
2021
Q1 		$1.3M Buy
7,695
+234
+3% +$49.3K ﹤0.01% 2797
2020
Q4 		$1.52M Buy
7,461
+395
+6% +$76.3K ﹤0.01% 2640
2020
Q3 		$1.36M Buy
7,066
+36
+0.5% +$8.07K ﹤0.01% 2548
2020
Q2 		$1.92M Buy
7,030
+1,851
+36% +$493K ﹤0.01% 2355
2020
Q1 		$1.45M Sell
5,179
-16
-0.3% -$4.9K ﹤0.01% 2349
2019
Q4 		$1.94M Buy
5,195
+12
+0.2% +$3.44K ﹤0.01% 2429
2019
Q3 		$1.69M Buy
5,183
+134
+3% +$45.5K ﹤0.01% 2480
2019
Q2 		$1.78M Buy
+5,049
New +$1.98M ﹤0.01% 2480

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nuveen's QTTB Position: Q2 2025 in Review

Nuveen sold out of Q32 Bio (QTTB) in Q2 2025, closing a stake of 55,886 shares — an estimated $92.2K sold.

Nuveen first reported a position in QTTB in Q2 2019 and held it in 15 quarters. The position peaked at $2.49M in Q3 2024. 61 funds tracked by Wall St. Rank hold QTTB as of Q2 2025.

  • Nuveen reported no remaining Q32 Bio position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 55,886 Q32 Bio shares in Q2 2025, an estimated $92.2K.
  • Nuveen first reported a position in Q32 Bio in Q2 2019 and held it in 15 quarters.
  • Nuveen's Q32 Bio position peaked at $2.49M in Q3 2024.
  • 61 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.